Results: Iress delivers stable half-year performance

The Iress Limited (ASX: IRE) share price is relatively flat after the company announced its financial results for the 6 months to 30 June 2019 today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Iress Limited (ASX: IRE) share price is relatively flat after the company announced its financial results for the 6 months to 30 June 2019 today.

a woman

What did Iress announce?

Iress is a technology company that provides software to the financial services industry, providing trading and market data and investment management information. The company's software is used by more than 9,000 businesses and boasts 500,000 users in Asia Pacific, Europe, North America and Africa.

The company's financial report saw segment profit increase 10% on the previous corresponding period with revenue growth driven by key businesses.

Highlights of Iress' financial report include:  

  • Group revenue up 5% to $241.8 million
  • Group segment profit up 10% to $74.1 million
  • Reported net profit after tax (NPAT) of $30.4 million
  • Net debt balance of $193.3 million
  • 10% franked interim dividend of 16 cents per share

Iress also reported that the company expects FY19 guidance to remain unchanged and in line with guidance.

How did Iress perform?

Iress' financial report outlines that growth has been driven by continued demand from private wealth and mortgages. Australian finance advice and revenue growth also continues, with increasing demand for data capability.

The successful acquisition of international market data provider QuantHouse has also aligned with Iress' strategy to service the global demand for market data. Iress chief executive Andrew Walsh said "demand and delivery for our software and services remains strong and technology continues to play an increasingly important role for financial services businesses globally."

Iress' APAC segment saw operating revenue increase 3% to $128.2 million due to strong demand from clients for software that provides live data and risk management. Trading and market data revenue also remained resilient, with revenue growth in Asia being driven by the rollout of online trading software Viewpoint.

Outlook for Iress

Iress continues to expect segment profit growth for FY19 to be between 6 and 11% on a constant currency basis. Non-operating costs are expected to be substantially lower for FY19 following the company's targeted and elevated investment decisions. The acquisition and integration of QuantHouse is expected to contribute around $4 to $6 million to non-operating costs. Beyond 2019, Iress expects continued industry change as a result of global economic uncertainty.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has recommended IRESS Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »